EIF2A and myeloid sarcoma: We demonstrated that EAE_postIF robustly activated PERK and its downstream markers (p-eIF2α, ATF4, CHOP), in agreement with recent studies showing that PERK plays a neuroprotective role in EAE and MS by enhancing cellular stress tolerance and limiting ER burden [17, 20, 45].